CCIA
GMED icon

Campbell & Co Investment Adviser’s Globus Medical GMED Stock Holding History

Campbell & Co Investment Adviser’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-56,286
Closed -$4.85M – 1160
2026
Q1 		$4.85M Buy
+56,286
New +$5.05M 0.28% 72
2025
Q4 		– Sell
-9,420
Closed -$539K – 1242
2025
Q3 		$539K Buy
+9,420
New +$542K 0.04% 698
2024
Q4 		– Sell
-34,634
Closed -$2.48M – 1161
2024
Q3 		$2.48M Buy
+34,634
New +$2.44M 0.18% 139
2024
Q1 		– Sell
-23,926
Closed -$1.28M – 1215
2023
Q4 		$1.28M Sell
23,926
-31,546
-57% -$1.54M 0.11% 276
2023
Q3 		$2.75M Buy
55,472
+51,369
+1,252% +$2.87M 0.33% 45
2023
Q2 		$244K Sell
4,103
-3,988
-49% -$227K 0.04% 738
2023
Q1 		$458K Buy
+8,091
New +$519K 0.09% 451
2019
Q3 		– Sell
-6,624
Closed -$280K – 655
2019
Q2 		$280K Buy
+6,624
New +$288K 0.13% 327
2018
Q4 		– Sell
-3,706
Closed -$210K – 393
2018
Q3 		$210K Buy
+3,706
New +$195K 0.14% 327

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return
AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
ACA
Anchor Capital Advisors Boston, Massachusetts $3.56B AUM 21.74% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Campbell & Co Investment Adviser's GMED Position: Q2 2026 in Review

Campbell & Co Investment Adviser sold out of Globus Medical (GMED) in Q2 2026, closing a stake of 56,286 shares — an estimated $4.85M sold.

Campbell & Co Investment Adviser first reported a position in GMED in Q3 2018 and held it in 9 quarters. The position peaked at $4.85M in Q1 2026. 293 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Campbell & Co Investment Adviser reported no remaining Globus Medical position as of Q2 2026 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 56,286 Globus Medical shares in Q2 2026, an estimated $4.85M.
  • Campbell & Co Investment Adviser first reported a position in Globus Medical in Q3 2018 and held it in 9 quarters.
  • Campbell & Co Investment Adviser's Globus Medical position peaked at $4.85M in Q1 2026.
  • 293 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.